Highbridge Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-15,697
Closed -$206K 1183
2016
Q4
$206K Buy
15,697
+252
+2% +$3.31K ﹤0.01% 895
2016
Q3
$266K Buy
+15,445
New +$266K ﹤0.01% 854
2016
Q2
Sell
-19,952
Closed -$379K 1162
2016
Q1
$379K Buy
+19,952
New +$379K 0.01% 591
2015
Q4
Sell
-159,571
Closed -$3.89M 946
2015
Q3
$3.89M Buy
+159,571
New +$3.89M 0.06% 293